Literature DB >> 30496533

Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial.

Christina S McCrae1, Jacob Williams2, Daniela Roditi2, Ryan Anderson2, Jennifer M Mundt2, Mary Beth Miller1, Ashley F Curtis1, Lori B Waxenberg2, Roland Staud3, Richard B Berry4, Michael E Robinson2.   

Abstract

STUDY
OBJECTIVES: To examine the effects of cognitive behavioral treatments for insomnia (CBT-I) and pain (CBT-P) in patients with comorbid fibromyalgia and insomnia.
METHODS: One hundred thirteen patients (Mage = 53, SD = 10.9) were randomized to eight sessions of CBT-I (n = 39), CBT-P (n = 37), or a waitlist control (WLC, n = 37). Primary (self-reported sleep onset latency [SOL], wake after sleep onset [WASO], sleep efficiency [SE], sleep quality [SQ], and pain ratings) and secondary outcomes (dysfunctional beliefs and attitudes about sleep [DBAS]; actigraphy and polysomnography SOL, WASO, and SE; McGill Pain Questionnaire; Pain Disability Index; depression; and anxiety) were examined at posttreatment and 6 months.
RESULTS: Mixed effects analyses revealed that both treatments improved self-reported WASO, SE, and SQ relative to control at posttreatment and follow-up, with generally larger effect sizes for CBT-I. DBAS improved in CBT-I only. Pain and mood improvements did not differ by group. Clinical significance analyses revealed the proportion of participants no longer reporting difficulties initiating and maintaining sleep was higher for CBT-I posttreatment and for both treatments at 6 months relative to control. Few participants achieved >50% pain reductions. Proportion achieving pain reductions of >30% (~1/3) was higher for both treatments posttreatment and for CBT-I at 6 months relative to control.
CONCLUSIONS: CBT-I and CBT-P improved self-reported insomnia symptoms. CBT-I prompted improvements of larger magnitude that were maintained. Neither treatment improved pain or mood. However, both prompted clinically meaningful, immediate pain reductions in one third of patients. Improvements persisted for CBT-I, suggesting that CBT-I may provide better long-term pain reduction than CBT-P. Research identifying which patients benefit and mechanisms driving intervention effects is needed. CLINICAL TRIAL: Sleep and Pain Interventions in Fibromyalgia (SPIN), clinicaltrials.gov, NCT02001077. © Sleep Research Society 2018. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CBT; cognitive behavioral treatments; comorbid chronic insomnia; fibromyalgia; pain; sleep

Mesh:

Year:  2019        PMID: 30496533      PMCID: PMC6424087          DOI: 10.1093/sleep/zsy234

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  26 in total

Review 1.  Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship.

Authors:  Alberto Herrero Babiloni; Beatrice P De Koninck; Gabrielle Beetz; Louis De Beaumont; Marc O Martel; Gilles J Lavigne
Journal:  J Neural Transm (Vienna)       Date:  2019-08-26       Impact factor: 3.575

2.  Effect of cognitive behavioural therapy on sleep and opioid medication use in adults with fibromyalgia and insomnia.

Authors:  Christina S McCrae; Ashley F Curtis; Mary Beth Miller; Neetu Nair; Himangshu Rathinakumar; Mattina Davenport; Jasmine R Berry; Kevin McGovney; Roland Staud; Richard Berry; Michael Robinson
Journal:  J Sleep Res       Date:  2020-03-03       Impact factor: 3.981

3.  Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia.

Authors:  Rongrong Zhu; Dongmei Wang; Huixia Zhou; Wenjia Wang; Shuochi Wei; Dachun Chen; Meihong Xiu; Li Wang; Xiang-Yang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-08-16       Impact factor: 5.760

4.  Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

5.  From bit player to key mechanism: the role of sleep in exercise.

Authors:  Christina S McCrae; Ashley F Curtis
Journal:  J Clin Sleep Med       Date:  2020-12-17       Impact factor: 4.062

6.  Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966.

Authors:  Brian J Miller; Karl-Heinz Herzig; Jari Jokelainen; Toni Karhu; Sirkka Keinänen-Kiukaanniemi; Marjo-Riitta Järvelin; Juha Veijola; Heimo Viinamäki; Erika Jääskeläinen; Matti Isohanni; Markku Timonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-07       Impact factor: 5.270

7.  Insomnia treatment effects among young adult drinkers: Secondary outcomes of a randomized pilot trial.

Authors:  Mary Beth Miller; Lindsey Freeman; Chan Jeong Park; Nicole A Hall; Chelsea Deroche; Pradeep K Sahota; Christina S McCrae
Journal:  Alcohol Clin Exp Res       Date:  2021-04-05       Impact factor: 3.455

8.  Cannabis use as a moderator of cognitive behavioral therapy for insomnia.

Authors:  Mary Beth Miller; Ryan W Carpenter; Lindsey K Freeman; Ashley F Curtis; Ali M Yurasek; Christina S McCrae
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

9.  The Epidemiology of Insomnia and Sleep Duration Across Mental and Physical Health: The SHoT Study.

Authors:  Børge Sivertsen; Mari Hysing; Allison G Harvey; Keith J Petrie
Journal:  Front Psychol       Date:  2021-06-14

10.  Neural activation changes in response to pain following cognitive behavioral therapy for patients with comorbid fibromyalgia and insomnia: a pilot study.

Authors:  Christina S McCrae; Jason G Craggs; Ashley F Curtis; Neetu Nair; Daniel Kay; Roland Staud; Richard B Berry; Michael E Robinson
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.